Point-of-care testing (POCT) continues to transform the delivery of healthcare and effect changes in both utilization and management of rapid diagnostic instruments. By enabling rapid diagnostic results at or near the point of patient treatment, the conveniences afforded by POCT can help optimize patient outcomes while boosting the quality of care delivery. However, as POCT adoption expands, healthcare... Read more
with Yen-Michael S. Hsu, MD, PhD, MBA, CABP
Co-Chief Medical Officer
Center for Cell and Gene Therapy and Adelson-NMDP Collection Center
Gift of Life Marrow Registry
Chimeric antigen receptor T-cell (CAR-T) therapy has revolutionized the treatment of hematologic malignancies in the hospital setting. This innovative immunotherapy is primarily used to target specific types of blood cancers,... Read more
www.medlabmag.com uses tracking technologies. The site may also
include cookies from third parties. By continuing to use this website, you consent
to the use of tracking technologies as defined in our
Privacy Policy that can be read by clicking here.